Introduction
============

β-Carboline alkaloids \[[@R1]\] are widespread in plants, animals and some are formed naturally in the biological system. Rinehart et al. \[[@R2]\] reported the isolation of β-carboline alkaloids such as eudistomins \[[@R3]\] and several of its analogues from the active Caribbean colonial tunicate *Eudistoma olivaceum.* β-Carboline alkaloids bearing a substituted phenylacetyl group at C-1 position such as eudistomin T (**1**) \[[@R4]\], eudistomin R (**2a**) and eudistomin S (**2b**) \[[@R5]\] were isolated by Cardellina et al. \[[@R6]\], and these compounds exhibit antimicrobial activity. Xestomanzamine A (**3**) \[[@R5]\] is a β-carboline alkaloid with an 1-methyl-1*H*-imidazole-5-acyl group at the C-1 position and was isolated from the Okinawan marine sponge *Xestopongia sp.* The other β-carboline alkaloids reported in the literature are fascaplysin (**4**) \[[@R7]\], eudistomin A (**5a**) \[[@R3]\], harmine (**5b**) \[[@R8]--[@R10]\], harmaline (**5c**) \[[@R11]\], and tetrahydroharmine (**5d**). Among these, methoxy substituted β-carboline alkaloids such as **5b**, **5c**, and **5d** are indigenously used as hallucinogenic drugs. Some β-carbolines, notably tryptoline (**5e**) and pinoline (**5f**), are produced naturally in the human body. Recently Heonjoong et al. isolated new β-carboline-based metabolites, designated as eudistomins Y~1~−Y~7~ (**6a**--**g**) \[[@R12]--[@R14]\] ([Fig. 1](#F1){ref-type="fig"}), from the tunicate of the genus *Eudistoma* and posses a benzoyl group at the C-1 position of the β-carboline structural framework. Eudistomins Y~1~−Y~7~ (**6a**--**6g**) were evaluated for their antibacterial activity. Eudistomin Y~6~ (**6f**) exhibits moderate antibacterial activity against the Gram-positive bacteria *Staphylococcus epidermis* and *Bacillus subtilis*.

![Natural products containing the β-carboline skeletal.](Beilstein_J_Org_Chem-10-471-g002){#F1}

Results and Discussion
======================

There are several approaches known in literature for the synthesis of β-carbolines. Most of the syntheses of eudistomin T (**1**) are generally carried out either from indole or its suitably substituted derivatives. The acylation of 2-(3-indolyl)ethyl isocyanide with phenylacetyl chloride followed by cyclization and aromatization is well documented in the literature for the synthesis of 1-benzoyldihydro-β-carbolines. The cyclization of the adduct, formed by the reaction of tryptamine with appropriately substituted 1,2,3-tricarbonyl compounds or with glyoxylic acid derivatives under Pictet--Spengler conditions is also reported in literature for the syntheses of eudistomin T (**1**) and eudistomin S (**2b**). Jenkins and co-workers reported the synthesis of fascaplysin (**4**) by the reaction of tryptamine with phenylacetyl chloride and carried out the aromatization under photo-oxidation conditions \[[@R15]--[@R16]\]. Lindsley and co-workers \[[@R17]\] reported the synthesis of eudistomins Y~1~−Y~7~ (**6a**--**6g**) under microwave conditions \[[@R18]\]. Considering the complexity involved in the synthesis of several of the starting materials used in the preparation of carbolines, especially tricarbonyl compounds, an alternate approach for the synthesis of 3*H*-β-carboline is sought after. Herein we described our successful efforts towards the synthesis of 1-benzoyldihydro-β-carbolines or dihydroeudistomin. The previously developed synthetic methodologies in our laboratory \[[@R19]--[@R24]\] were utilized for the synthesis of eudistomin Y (**6**) and its analogues

![Retrosynthetic analysis of **6**.](Beilstein_J_Org_Chem-10-471-g004){#C1}

The disconnection approach employed in the synthesis of 1-benzoyl*-*β-carboline is described in [Scheme 1](#C1){ref-type="fig"}. Accordingly eudistomin Y (**6**) could be obtained by the aromatization of dihydro-β-carboline **12**. The dihydro-β-carboline **12** in turn could be synthesized from ketoamide **9** under Lewis acid mediated Bischler--Napieralski reaction. The key intermediate, ketoamide **9** required for the synthesis could easily be accessed from tryptamine (**10**) and appropriately substituted 2,2-dibromo-1-phenylethanone (**11**) \[[@R25]--[@R26]\] under oxidative amidation conditions.

The oxidative amidation strategy employed in the current synthesis is previously reported from our group by the reaction of a secondary amine with aryl-2,2-dibromo-1-ethanone under aerial oxidation conditions \[[@R24]\]. Later this methodology was successfully employed in the synthesis of isoquinoline alkaloids \[[@R27]\]. The synthesis of eudistomin Y (**6**) was initiated with the conversion of the respective 2,2-dibromo-1-phenylethanone to the corresponding Schiff base **14** by reaction with tryptamine in presence of NaI. The Schiff base on in situ oxidation with cumene hydroperoxide afforded an unstable oxaziridine derivative **15**. Ring opening of the oxaziridine derivative **15** in presence of base afforded ketoiminol **16**, which on iminol--amide tautomerism provided the required *α*-ketoamide **9** ([Scheme 2](#C2){ref-type="fig"}). It was possible to limit the formation of benzamide impurity **17** in the reaction to \<15% ([Table 1](#T1){ref-type="table"}); however, we were unable to avoid the formation of **17** under any of the attempted reaction conditions ([Scheme 3](#C3){ref-type="fig"}).

![Plausible mechanism of the oxidative amidation for **9**.](Beilstein_J_Org_Chem-10-471-g005){#C2}

###### 

Effect of solvent and additive on the ratio of **9** and **17**.

  --- ------ -------------------- ------------------- ------------------------- ------------------
      Base   Solvent /Additives   Reaction time (h)   *α-*Ketoamide **9** (%)   Amide **17** (%)
                                                                                
  1   TEA    DMSO/NaI             6                   60                        15
  2   TEA    Sulfolane/NaI        16                  52                        15
  3   TEA    DMSO                 25                  42                        25
  --- ------ -------------------- ------------------- ------------------------- ------------------

![Synthesis of *α-*ketoamide **9**.](Beilstein_J_Org_Chem-10-471-g006){#C3}

The *α*-ketoamide **9** thus obtained by the oxidative amidation methodology was subjected to a Bischler--Napieralski cyclodehydration reaction in presence of POCl~3~ \[[@R27]\], however under these conditions 2,9-dihydro-β-carboline derivative **7** was obtained as the major product (less than 10% yield) instead of 4-9-dihydro-β-carboline derivative **12** ([Scheme 4](#C4){ref-type="fig"}). Our attempts to improve the yield of **7** under Bischler--Napieralski cyclodehydration reaction conditions using POCl~3~ as the Lewis acid were proved to be futile. This prompted us to test the efficiency of other Lewis acids in this cyclodehydration reaction. The Bischler--Napieralski cyclodehydration reaction was then carried out with different Lewis acids such as BF~3~·Et~2~O, SnCl~4~, TiCl~4~ etc., in mutiple solvents under various reaction conditions. The best conversion was obtained when the reaction was conducted in BF~3~·Et~2~O in ether at 25--30 °C and the product dihydro-β-carboline **7** was isolated in 55% of yield.

![Synthesis of dihydroeudistomin Y analogues.](Beilstein_J_Org_Chem-10-471-g007){#C4}

The formation of isomeric 2,9-dihydro-β-carboline derivative **7** as the major product in Bischler--Naperalski reaction conditions is explained in [Scheme 5](#C5){ref-type="fig"}. The initially formed spirocyclic compound **18** undergoes intramolecular rearrangement and afforded the dihydrocarboline framework **19**, which on aromatization yielded **20**. Based on the reaction conditions **8** can be obtained from **20** after aqueous work-up or at higher temperature heating, **20** undergoes a sequential prototropic migration leading to the formation of 2,9-dihydro-β-carboline derivative **7.** To the best of our knowledge, this is a novel method for the synthesis of 1-benzoyldihydrocarboline from *α*-ketoamide **9** \[[@R28]\].

![Plausible mechanism for the formation of **7**.](Beilstein_J_Org_Chem-10-471-g008){#C5}

The structure of 2,9-dihydro-β-carboline **7** and 1-hydroxytetrahydro-β-carboline **8** was confirmed by various NMR techniques such as 2D NMR, COSY as well as HSQC ([Fig. 2](#F2){ref-type="fig"}). The coupling of the H^2^ proton with both H^1^ and H^3^ protons is clearly evident in the COSY for **7a**, whereas the OH proton in **8a** shows a high nOe ([Scheme 6](#C6){ref-type="fig"}).

![Rearrangement of **8a** into **7a** and coupling interactions of **7a**.](Beilstein_J_Org_Chem-10-471-g009){#C6}

![COSY and HSQC of **8a** and **7a**.](Beilstein_J_Org_Chem-10-471-g003){#F2}

Dihydro-β-carboline **7** was then subjected to an aromatization reaction to obtain eudistomin Y (**6**). The aromatization reaction was attempted with oxidizing agents such as DDQ and MnO~2~ as per the reported conditions in literature. The formation of product **6** was confirmed by LCMS analysis of the crude reaction mixture. However under these conditions product **6** was observed in less than 5% and our attempt to isolate the eudistomin Y (**6**) in pure form was not successful. The oxidation of compound **7** with oxygen, KMnO~4~, MnO~2~ and TBHP as well as dehydrogenation with DBU in different solvents at various temperatures also failed and did not yield the required product. Attempted oxidation of compound **7** under microwave irradiation conditions was also not successful. Probably under all aforementioned conditions, formation of the stable enol **21** might have retarded the aromatization during the course of dehydrogenation reaction of dihydro-β-carboline **7**.

Utilizing the oxidative amidation Bischler--Napieralski reaction conditions we have synthesized a number of dihydro-β-carbolines ([Table 2](#T2){ref-type="table"}) in moderate to good yields. The structures of these compounds were confirmed by spectral and analytical methods.

###### 

Synthesis of dihydro-*β*-carbolines^a^.

  ---- -------------------------------------------- -------------------------------------------- -------------------- -------------------------------------------- ------------------------------ --------------------------------------------
       Dibromo-\                                    *α*-Ketoamide **9**                          Yield of **9** (%)   2,9-Dihydro-\                                Yield of **7** and **8** (%)   1-Hydroxy-4,9-tetra-\
       ethanone **11**                                                                                                eudistomin **7**                                                            hydroeudistomin **8**

                                                                                                                                                                                                  

  1    ![](Beilstein_J_Org_Chem-10-471-i001.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i002.jpg)\   60                   ![](Beilstein_J_Org_Chem-10-471-i003.jpg)\   40 (**7a**)\                   ![](Beilstein_J_Org_Chem-10-471-i004.jpg)\
       **11a**                                      **9a**                                                            **7a**                                       15 (**8a**)                    **8a**

  2    ![](Beilstein_J_Org_Chem-10-471-i005.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i006.jpg)\   57                   ![](Beilstein_J_Org_Chem-10-471-i007.jpg)\   48 (**7b**)                    **8b**\
       **11b**                                      **9b**                                                            **7b**                                                                      not isolated

  3    ![](Beilstein_J_Org_Chem-10-471-i008.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i009.jpg)\   52                   ![](Beilstein_J_Org_Chem-10-471-i010.jpg)\   38 (**7c**)                    **8c**\
       **11c**                                      **9c**                                                            **7c**                                                                      not isolated

  4    ![](Beilstein_J_Org_Chem-10-471-i011.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i012.jpg)\   45                   ![](Beilstein_J_Org_Chem-10-471-i013.jpg)\   25 (**7d**)\                   ![](Beilstein_J_Org_Chem-10-471-i014.jpg)\
       **11d**                                      **9d**                                                            **7d**                                       12 (**8d**)                    **8d**

  5    ![](Beilstein_J_Org_Chem-10-471-i015.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i016.jpg)\   38                   ![](Beilstein_J_Org_Chem-10-471-i017.jpg)\   20 (**7e**)                    **8e**\
       **11e**                                      **9e**                                                            **7e**                                                                      not isolated

  6    ![](Beilstein_J_Org_Chem-10-471-i018.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i019.jpg)\   55                   ![](Beilstein_J_Org_Chem-10-471-i020.jpg)\   38 (**7f**)                    **8f**\
       **11f**                                      **9f**                                                            **7f**                                                                      not isolated

  7    ![](Beilstein_J_Org_Chem-10-471-i021.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i022.jpg)\   50                   **7g**\                                      45 (**8g**)                    ![](Beilstein_J_Org_Chem-10-471-i023.jpg)\
       **11g**                                      **9g**                                                            not isolated                                                                **8g**

  8    ![](Beilstein_J_Org_Chem-10-471-i024.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i025.jpg)\   52                   ![](Beilstein_J_Org_Chem-10-471-i026.jpg)\   46 (**7h**)                    **8h**\
       **11h**                                      **9h**                                                            **7h**                                                                      not isolated

  9    ![](Beilstein_J_Org_Chem-10-471-i027.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i028.jpg)\   60                   ![](Beilstein_J_Org_Chem-10-471-i029.jpg)\   35 (**7i**)\                   ![](Beilstein_J_Org_Chem-10-471-i030.jpg)\
       **11i**                                      **9i**                                                            **7i**                                       20 (**8i**)                    **8i**

  10   ![](Beilstein_J_Org_Chem-10-471-i031.jpg)\   ![](Beilstein_J_Org_Chem-10-471-i032.jpg)\   42                   **7j**\                                      42 (**8j**)                    ![](Beilstein_J_Org_Chem-10-471-i033.jpg)\
       **11j**                                      **9j**                                                            not isolated                                                                **8j**
  ---- -------------------------------------------- -------------------------------------------- -------------------- -------------------------------------------- ------------------------------ --------------------------------------------

^a^All products were characterized by ^1^H NMR, ^13^C NMR, Mass and IR.

Conclusion
==========

In conclusion, we have developed an oxidative amidation Bischler--Napieralski reaction methodology for the synthesis of dihydroeudistomin Y (**7a**--**7i**). A number of 1-benzoyl dihydro-β-carboline derivates have been synthesized as a part of these studies. The oxidative amidation Bischler--Napieralski reaction provides a simple and direct method for the synthesis of carbolines, which are otherwise synthesized by multistage reactions utilizing starting materials which are not readily available.

Experimental
============

General procedure for the synthesis of α-ketoamides (**9a**--**9j**)
--------------------------------------------------------------------

A mixture of 2,2-dibromo-1-phenylethanone (**11a**, 6.0 g, 21.6 mmol) and sodium iodide (6.48 g, 43.2 mmol) in dimethyl sulfoxide (30.0 mL) at 25--45 °C was stirred for 40--50 minutes. Triethylamine (6.55 g, 64.8 mmol) and tryptamine (**10**, 3.45 g, 21.6 mmol) were then added to the mixture under a N~2~ atmosphere and it was stirred for 1--2 h at 25--45 °C. Then cumene hydroperoxide (88% *n*-hexane solution, 3.73 g, 21.6 mmol) was added to the mixture over a period of five minutes (exothermic reaction), and it was further stirred for another 3--6 h at the same temperature. After completion of the reaction (TLC), ice water was added to the mixture and extracted with DCM (2 × 50 mL). The DCM layer was washed with aq sodium bisulfite solution (50 mL) followed by brine (50 mL) and H~2~O (2 × 60 mL). The organic layer was dried (anhyd. Na~2~SO~4~) and evaporated to dryness under reduced pressure. The obtained crude product was subjected to CC purification and afforded the desired product in moderate to good yields.

***N*** **-(2-(1** ***H*** **-Indol-3-yl)ethyl)-2-oxo-2-phenylacetamide (9a):** 60% yield; mp 135--136.7 °C; IR (cm^--1^): 3408, 3386, 2927, 2862, 1663, 1531, 1288, 1248, 1218, 1093, 1080, 1071, 838, 742; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.32 (d, *J* = 8 Hz, 2H), 8.05 (s, 1H, NH), 7.63 (dd, *J* = 8.4, 6.8 Hz, 2H), 7.47 (t, *J* = 8 Hz, 2H), 7.38 (d, *J* = 8 Hz, 1H), 7.22 (dd, *J* = 6.0, 7.2 Hz, 1H), 7.15 (dd, *J* = 1.2, 6.8 Hz, 1H), 7.12 (dd, *J* = 2.0, 8.8 Hz, 1H), 7.10 (s, 1H), 3.75 (q, *J* = 6.8 Hz, 2H), 3.09 (t, *J* = 6.8 Hz, 2H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 190.4, 164.8, 136.1, 134.3, 132.8, 129.6 (2C), 128.7 (2C), 127.1, 122.8, 120.8, 118.2 (2C), 111.2 (2C), 40.7, 24.7; MS *m*/*z* (%): 293 (M + 1), 315 (M + 23).

***N*** **-(2-(1** ***H*** **-Indol-3-yl)ethyl)-2-oxo-2-(** ***p*** **-tolyl)acetamide (9b):** 57% yield; mp 116.8--118.1 °C; IR (cm^--1^): 3340, 3255, 3093, 2841, 1661, 1644, 1514, 1457, 1310, 1263, 1224, 1169, 1024, 849, 798, 742; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.24 (d, *J* = 8 Hz, 2H), 8.06 (s, 1H, NH), 7.64 (d, *J* = 8 Hz, 1H), 7.39 (d, *J* = 8 Hz, 1H), 7.21 (t, *J* = 7.2 Hz, 2H), 7.13 (t, *J* = 7.2 Hz, 2H), 7.07 (d, *J* = 2.4 Hz, 1H), 3.73 (d, *J* = 6.4 Hz, 2H), 3.07 (t, *J* = 6.8 Hz, 2H), 2.42 (s, 3H): ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 190.1, 165.2, 145.2, 136.2, 132.3, 129.8, 129.4, 127.1, 125.7, 122.8, 120.9 118.3 (2C), 114.2, 111.3 (2C), 55.7, 24.8, 21.4; MS *m*/*z* (%): 307.5 (M + 1), 329.5 (M + 23).

***N*** **-(2-(1** ***H*** **-Indol-3-yl)ethyl)-2-oxo-2-(4-(trifluoromethyl)phenyl)acetamide (9c):** 52% yield; mp 139.8--140.1 °C; IR (cm^−1^): 3338, 2938, 2842, 1640, 1334, 1224, 1157, 1135, 1075, 935, 842, 794, 747; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.42 (d, *J* = 8 Hz, 2H), 8.06 (s, 1H, NH), 7.73 (d, *J* = 8 Hz, 2H), 7.64 (d, *J* = 8 Hz, 1H), 7.40 (d, *J* = 8 Hz, 1H), 7.22 (t, *J* = 7.2 Hz, 1H), 7.14 (t, *J* = 7.2 Hz, 2H), 3.75 (d, *J* = 6.8 Hz, 2H), 3.09 (t, *J* = 6.8 Hz, 2H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 189.0, 163.7, 136.1 (2C), 130.4 (2C), 127.1, 125.6 (2C), 122.8, 120.8 118.2 (2C), 111.2 (2C), 39.2, 24.7; MS *m*/*z* (%): 383 (M + 1), 405 (M + 23).

***N*** **-(2-(1** ***H*** **-Indol-3-yl)ethyl)-2-(4-fluorophenyl)-2-oxoacetamide (9d):** 45% yield; mp 138.5--141.2 °C; IR (cm^−1^): 3338, 3335, 2923, 2858, 1682, 1651, 1595, 1522, 1352, 1273, 1228, 1152, 850, 798, 742; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.41 (dd, *J* = 5.2, 2 Hz, 2H), 8.09 (s, 1H, NH), 7.63 (d, *J* = 7.6 Hz, 1H), 7.38 (d, *J* = 8 Hz, 1H), 7.21 (t, *J* = 7.2 Hz, 1H), 7.14 (t, *J* = 2 Hz, 1H), 7.13 to 7.11 (m, 1H), 7.10 (t, *J* = 2 Hz, 1H), 7.06 (d, *J* = 1.6 Hz, 1H), 3.73 (d, *J* = 6.4 Hz, 2H), 3.07 (t, *J* = 6.8 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ~c~ 188.6, 164.3, 163.0, 136.1, 132.9, 132.7, 129.6, 127.1, 122.8, 120.9, 116.1, 115.7, 118.2 (2C), 111.2 (2C), 39.2, 24.7; MS *m*/*z* (%): 311.5 (M + 1), 333.4 (M + 23).

***N*** **-(2-(1** ***H*** **-Indol-3-yl)ethyl)-2-(3-nitrophenyl)-2-oxoacetamide (9e):** 38% yield; mp 138.1--139.5 °C; IR (cm^−1^): 3364, 3331, 3121, 2860, 1662, 1523, 1346, 1263, 1212, 1098, 815, 752, 725; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 9.13 (s, 1H), 8.68 (d, *J* = 7.2 Hz, 1H), 8.46 (d, *J* = 7.2 Hz, 2H), 8.09 (s, 1H, NH), 7.67 (dd, *J* = 8 Hz, 1H), 7.40 (d, *J* = 8 Hz, 1H), 7.25 to 7.10 (m, 3H, ArH), 3.77 (d, *J* = 6.6 Hz, 2H), 3.10 (t, *J* = 7 Hz, 2H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 187.3, 162.8, 147.7, 136.1, 135.8, 134.1, 130.4, 128.2, 127.2, 124.2, 122.7, 120.8, 118.2, 111.2, 39.2, 24.7; MS *m*/*z* (%): 338.5 (M^+^), 360.5 (M^+^, 23).

General procedure for the synthesis of dihydroeudistomin (**7a**--**7j**)
-------------------------------------------------------------------------

To a stirred solution of *N*-(2-(1*H*-indol-3-yl)ethyl)-2-oxo-2-phenylacetamide (**9a**, 2.0 g, 6.8 mmol) in diethyl ether (20 mL) was added 48% boron trifluoride etherate (10.1 g, 34.2 mmol) in a round-bottom flask under a N~2~ atmosphere, and the mixture was stirred at 25--30 °C for 2 h. After TLC indication for absence of starting material toluene (20 mL) was added. Then mixture was heated to 55--70 °C and it was maintained under stirring at that temperature for 4--8 h (TLC). The mixture was cooled to 25--30 °C and it was poured into a pre-cooled sat. NaHCO~3~ solution (160 mL) at 10 °C. The product was then extracted with ethyl acetate (2 × 25 mL) and the organic layer was washed with 10% NaHCO~3~ solution (25 mL) and dried (anhyd. Na~2~SO~4~). The solvent was distilled off under reduced pressure and the crude residue was subjected to column chromatography purification. The product was obtained in good to moderate yields.

**(2,9-Dihydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)(phenyl)methanone (7a):** 40% yield; mp 228.5--230.6 °C; ^1^H NMR (400 MHz, DMSO-*d* ~6~) δ~H~ 11.37 (br s, 1H, NH), 9.68 (d, *J* = 5.2 Hz, 1H), 7.65 (d, *J* = 8.0 Hz, 1H), 7.42 (d, *J* = 7.6 Hz, 1H), 7.26 (t, *J* = 7.4 Hz, 2H), 7.22 (d, *J* = 7.2 Hz, 1H), 7.16 (t, *J* = 7.6 Hz, 1H), 7.08 (t, *J* =7.2 Hz, 1H), 7.01 (d, *J* = 7.2 Hz, 2H), 6.34 (d, *J* = 8.8 Hz, 1H), 5.77 (dd, *J* = 3.2 & 5.6 Hz, 1H), 5.29 (s, 1H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 167.1, 136.4, 136.1, 130.8, 128.5 (2C), 127.2, 126.6 (2C), 125.9, 122.0, 119.6, 118.7, 118.2, 111.6, 109.9, 105.7, 53.2; MS *m*/*z* (%): 275.1 (M + 1), 297.2 (M + 23); HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~18~H~15~N~2~O, 275.1184; found, 275.1173.

**(1-Hydroxy-2,3,4,9-tetrahydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)(phenyl)methanone (8a):** 15% yield; mp 138.5--141.2 °C; ^1^H NMR (400 MHz, DMSO-*d* ~6~) δ~H~ 10.93 (s, 1H), 8.52 (t, *J* = 5.2 Hz, 1H, NH), 7.44 (d, *J* = 6.8 Hz, 2H), 7.33 to 7.26 (m, 3H, ArH), 7.11 (t, *J* = 6.0 Hz, 1H), 7.06 (d, *J* = 5.6 Hz, 2H), 7.00 (t, *J* = 6.0 Hz, 1H), 6.13 (s, 1H, D~2~O exchangable proton), 3.10--3.02 (m, 2H), 2.88--2.49 (m, 2H); ^13^C NMR (100 MHz, DMSO--*d* ~6~) δ~c~ 173.9, 143.9, 135.0, 131.0, 128.3 (2C), 127.8, 127.8, 126.0 (2C), 121.3, 118.5, 117.9, 111.5, 108.4, 75.6 (alkoxy carbon), 38.3, 25.2. HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~18~H~17~N~2~O~2~, 293.1290; found, 293.1333; HRMS of dehydrated **8a** (EI) *m*/*z*: \[M\]^+^ calcd for C~18~H~15~N~2~O, 275.1184; found, 275.1220.

**(2,9-Dihydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)(** ***p*** **-tolyl)methanone (7b):** 48% yield; mp 213.2--215.7 °C; IR (cm^−1^): 3222, 3179, 3043, 2940, 1656, 1625, 1558, 1479, 1335, 1246, 1065, 802, 768, 739; ^1^H NMR (400 MHz, DMSO-*d* ~6~) δ~H~ 11.36 (br s, 1H, NH), 9.64 (d, *J* = 4.8 Hz, 1H), 7.64 (d, *J* = 7.6 Hz, 1H), 7.41 (d, *J* = 8.0 Hz, 1H), 7.15 (t, *J* = 7.6 Hz, 1H), 7.10 (d, *J* = 7.6 Hz, 1H), 7.06 (d, *J* = 7.6 Hz, 2H), 6.89 (d, *J* = 8.0 Hz, 2H), 6.32 (d, *J* = 8.4 Hz, 1H), 5.76 (dd, *J* = 3.6 & 5.6 Hz, 1H), 5.23 (s, 1H), 2.20 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~ + DMSO-*d* ~6~) δ~c~ 166.3, 135.1, 134.9, 131.5, 129.7, 127.5 (2H), 125.4 (2C), 124.6, 120.3, 118.1, 117.1, 116.5, 110.1, 108.5, 104.5, 51.6, 19.5; MS *m/z* (%): 289.5 (M + 1), 311.5 (M + 23); HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~19~H~17~N~2~O, 289.1341; found, 289.1329.

**(2,9-Dihydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)(4-(trifluoromethyl)phenyl)methanone (7c):** 38% yield. mp 162--164 °C; IR (cm^−1^): 3222, 3185, 3042, 2937, 2835, 1657, 1624, 1509, 1456, 1249, 1177, 1055, 1032, 848, 810, 770, 742; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.10 (s, 1H), 7.69 (d, *J* = 7.6 Hz, 1H), 7.58 (d, *J* = 8.0 Hz, 2H), 7.38 (t, *J* = 8.0 Hz, 2H), 7.29--7.21 (m, 4H), 6.48 (d, *J* = 8.8 Hz, 1H), 5.94 (dd, *J* = 3.6 & 5.6 Hz, 1H), 5.19 (s, 1H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 166.0, 140.5, 136.3, 129.9, 127.9, 127.6, 127.4 (2C), 125.6 (doublet), 125.3 (2C), 121.9, 119.5, 118.7, 118.1, 111.6, 109.9, 105.7, 52.7; MS *m*/*z* (%): 343 (M + 1); HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~19~H~14~N~2~OF~3~, 343.1058; found, 343.1038.

**(2,9-dihydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)(4-fluorophenyl)methanone (7d):** 25% yield; mp 230.6--232.2 °C; IR (cm^−1^): 3351, 3279, 3083, 2895, 2839, 1659, 1605, 1508, 1459, 1304, 1234, 1161, 1072, 956, 837, 747; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 8.12 (s, 1H), 7.68 (d, *J* = 7.6 Hz, 1H), 7.37 (d, *J* = 7.6 Hz, 1H), 7.27--7.19 (m, 4H, ArH), 7.00 (t, *J* = 8.8 Hz, 2H), 6.51 (d, *J* = 8.4 Hz, 1H), 5.94 (dd, *J* = 3.6 & 4.8 Hz, 1H), 5.08 (s, 1H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 166.7, 162.4, 136.3, 132.1, 132.1, 130.6 (doublet), 128.6 (2C), 128.6, 125.7, 121.9, 119.5, 118.7, 118.1, 115.3, 115.1, 111.6, 109.8, 105.6, 52.3; MS *m*/*z* (%): 293 (M + 1); HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~18~H~14~N~2~OF, 293.1090; found, 293.1073.

**(4-Fluorophenyl)(1-hydroxy-2,3,4,9-tetrahydro-1** ***H*** **-pyrido\[3,4-** ***b*** **\]indol-1-yl)methanone (8d):** 12% yield; mp 185--187 °C; IR (cm^−1^): 3268, 3178, 3041, 2934, 1658, 1626, 1506, 1471, 1335, 1239, 1225, 1156, 1014, 976, 840, 816, 738; ^1^H NMR (400 MHz, CDCl~3~ + DMSO-*d* ~6~) δ~H~ 9.65 (s, 1H), 7.89 (t, *J* = 6.8 Hz, 1H), 7.47 (t, *J* = 9.4 Hz, 3H), 7.22--7.08 (m, H, ArH), 6.96 (t, *J* = 8.8 Hz, 2H), 5.92 (s, 1H), 3.24--3.19 (m, 2H), 2.94 (m, 2H); ^13^C NMR (100 MHz, DMSO-*d* ~6~) δ~c~ 173.6, 140.3, 135.0, 130.8, 128.2, 128.1, 127.7, 121.4, 118.5, 118.0, 115.3, 114.9, 111.5, 108.5, 75.0, 25.1; MS *m*/*z* (%): 293 (M + 1), 315 (M + 23); HRMS (EI) *m*/*z*: \[M\]^+^ calcd for C~18~H~14~N~2~OF, 293.1090; found, 293.1070.
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